Scientific References

  1. Yamamoto ES, de Jesus JA, Bezerra-Souza A, Brito JR, Lago JHG, Laurenti MD, Passero LFD. Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp. Bioorg Chem. 2020 Sep;102:104056. doi: 10.1016/j.bioorg.2020.104056. Epub 2020 Jul 2. PMID: 32653607.
  2. Vennewald I, Klemm E. Otomycosis: Diagnosis and treatment. Clin Dermatol. 2010 Mar 4;28(2):202-11. doi: 10.1016/j.clindermatol.2009.12.003. PMID: 20347664.
  3. Jimenez-Garcia L, Celis-Aguilar E, Díaz-Pavón G, Muñoz Estrada V, Castro-Urquizo Á, Hernández-Castillo N, Amaro-Flores E. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial. Braz J Otorhinolaryngol. 2020 May-Jun;86(3):300-307. doi: 10.1016/j.bjorl.2018.12.007. Epub 2019 Feb 18. PMID: 30826311.
  4. Taplin D. Superficial mycoses. J Invest Dermatol. 1976 Jul;67(1):177-81. doi: 10.1111/1523-1747.ep12513020. PMID: 778288.
  5. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008 Apr;72(4):453-9. doi: 10.1016/j.ijporl.2007.12.005. Epub 2008 Feb 14. PMID: 18279975.
  6. Amsel LP. Comparative in vitro and in vivo antifungal activity of tolnaftate and various undecylenates: a rebuttal. J Pharm Sci. 1980 Jun;69(6):741-2. doi: 10.1002/jps.2600690639. PMID: 7205601.
  7. Iwata K, Yamashita T, Uehara H. In vitro and in vivo activities of piritetrate (M-732), a new antidermatophytic thiocarbamate. Antimicrob Agents Chemother. 1989 Dec;33(12):2118-25. doi: 10.1128/aac.33.12.2118. PMID: 2619275; PMCID: PMC172832.
  8. Gupta MP, Kapur N, Bala I, Khuller GK. Studies on the mode of action of tolnaftate in Microsporum gypseum. J Med Vet Mycol. 1991;29(1):45-52. doi: 10.1080/02681219180000081. PMID: 2061794.
  9. Keczkes K, Leighton I, Good CS. Topical treatment of dermatophytoses and candidoses. Practitioner. 1975 Mar;214(1281):412-7. PMID: 1096122.
  10. Fuerst JF, Cox GF, Weaver SM, Duncan WC. Comparison between undecylenic acid and tolnaftate in the treatment of tinea pedis. Cutis. 1980 May;25(5):544-6, 549. PMID: 6991217.
  11. Robinson HM Jr, Raskin J. Tolnaftate, a potent topical antifungal agent. Arch Dermatol. 1965 Apr;91(4):372-6. doi: 10.1001/archderm.91.4.372. PMID: 9626090.
  12. Smith EB, Dickson JE, Knox JM. Tolnaftate powder in prophylaxis of tinea pedis. South Med J. 1974 Jul;67(7):776-8. doi: 10.1097/00007611-197407000-00008. PMID: 4600407.
  13. Charney P, Torres VM, Mayo AW, Smith EB. Tolnaftate as a prophylactic agent for tinea pedis. Int J Dermatol. 1973 May-Jun;12(3):179-85. doi: 10.1111/j.1365-4362.1973.tb00034.x. PMID: 4704166.Sakkas H, Papadopoulou C. Antimicrobial Activity of Basil, Oregano, and Thyme Essential Oils. J Microbiol Biotechnol. 2017 Mar 28;27(3):429-438. doi: 10.4014/jmb.1608.08024. PMID: 27994215.
  14. Liu Q, Meng X, Li Y, Zhao CN, Tang GY, Li HB. Antibacterial and Antifungal Activities of Spices. Int J Mol
  15. Sci. 2017 Jun 16;18(6):1283. doi: 10.3390/ijms18061283. PMID: 28621716; PMCID: PMC5486105.
  16. Mediouni S, Jablonski JA, Tsuda S, Barsamian A, Kessing C, Richard A, Biswas A, Toledo F, Andrade VM, Even Y, Stevenson M, Tellinghuisen T, Choe H, Cameron M, Bannister TD, Valente ST. Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells. J Virol. 2020 Jul 16;94(15):e00147-20. doi: 10.1128/JVI.00147-20. PMID: 32461309; PMCID: PMC7375364.
  17. Brochot A, Guilbot A, Haddioui L, Roques C. Antibacterial, antifungal, and antiviral effects of three essential oil blends. Microbiologyopen. 2017 Aug;6(4):e00459. doi: 10.1002/mbo3.459. Epub 2017 Mar 14. PMID: 28296357; PMCID: PMC5552930.
  18. Donato R, Sacco C, Pini G, Bilia AR. Antifungal activity of different essential oils against Malassezia pathogenic species. J Ethnopharmacol. 2020 Mar 1;249:112376. doi: 10.1016/j.jep.2019.112376. Epub 2019 Nov 6. PMID: 31704415.
  19. Bergsson, G., Arnfinnsson, J., Steingrímsson O, & Thormar, H. (2001). In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrobial agents and chemotherapy, 45(11), 3209–3212.
    https://doi.org/10.1128/AAC.45.11.3209-3212.2001
  20. Bae YS, Rhee MS. Short-Term Antifungal Treatments of Caprylic Acid with Carvacrol or Thymol Induce Synergistic 6-Log Reduction of Pathogenic Candida albicans by Cell Membrane Disruption and Efflux Pump Inhibition. Cell Physiol Biochem. 2019;53(2):285-300. doi: 10.33594/000000139. PMID: 31334617.
  21. Suchodolski, J., Derkacz, D., Bernat, P., & Krasowska, A. (2021). Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B. Scientific reports, 11(1), 6519. 
    https://doi.org/10.1038/s41598-021-86012-9
  22. Murzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One. 2010 Aug 10;5(8):e12050. doi: 10.1371/journal.pone.0012050. PMID: 20706577; PMCID: PMC2919387.
  23. Salari, S., & Ghasemi Nejad Almani, P. (2020). Antifungal effects of Lactobacillus acidophilus and Lactobacillus plantarum against different oral Candida species isolated from HIV/ AIDS patients: an in vitro study. Journal of oral microbiology, 12(1), 1769386. 
    https://doi.org/10.1080/20002297.2020.1769386.
  24. Vilela, S. F., Barbosa, J. O., Rossoni, R. D., Santos, J. D., Prata, M. C., Anbinder, A. L., Jorge, A. O., & Junqueira, J. C. (2015). Lactobacillus acidophilus ATCC 4356 inhibits biofilm formation by C. albicans and attenuates the experimental candidiasis in Galleria mellonella. Virulence, 6(1), 29–39. 
    https://doi.org/10.4161/21505594.2014.981486
  25. Schaller, M., & Schaller, M. (n.d.). How Lactobacillus bacteria fight Candida albicans infections - Healthcare industry. 1–4. https://www.gesundheitsindustrie-bw.de/en/article/news/how-lactobacillus-bacteria-fight-candida-albicans-infections/
  26. Collins, E. B., & Hardt, P. (1980). Inhibition of Candida albicans by Lactobacillus acidophilus. Journal of Dairy Science, 63(5), 830–832. 
    https://doi.org/10.3168/jds.S0022-0302(80)83013-X
  27. Shireen, F., Manipal, S., & Prabu, D. (2015). Anti-fungal activity of Aloe vera: In vitro study. SRM Journal of Research in Dental Sciences, 6(2), 92.
  28. Jain S, Mujoo S, Daga M, Kalra S, Nagi R, Laheji A. Comparison of antifungal effect of Aloevera gel and Triphala: An in vitro study. J Indian Acad Oral Med Radiol 2017;29:90-4
  29. Saniasiaya, J., Salim, R., Mohamad, I., & Harun, A. (2017). Antifungal Effect of Malaysian Aloe vera Leaf Extract on Selected Fungal Species of Pathogenic Otomycosis Species in In Vitro Culture Medium. Oman medical journal, 32(1), 41–46. 
    https://doi.org/10.5001/omj.2017.08
  30. Kosalec I, Pepeljnjak S, Kustrak D. Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae). Acta Pharm. 2005 Dec;55(4):377-85. PMID: 16375827.
  31. Shin EH, Song BG, Lee IH, Park MY, Ahn YJ, Chang KS. Repellency of cassia bark, eucalyptus, and star anise oils and their major constituents to Leptotrombidium pallidum (Acari: Trombiculidae). J Med Entomol. 2013 May;50(3):579-84. doi: 10.1603/me12129. PMID: 23802452.
  32. Staniszewska M, Bondaryk M, Kazek M, Gliniewicz A, Braunsdorf C, Schaller M, Mora-Montes HM, Ochal Z. Effect of serine protease KEX2 on Candida albicans virulence under halogenated methyl sulfones. Future Microbiol. 2017 Mar;12:285-306. doi: 10.2217/fmb-2016-0141. Epub 2017 Feb 24. PMID: 28287299.
  33. Zawrotniak, M., Bochenska, O., Karkowska-Kuleta, J., Seweryn-Ozog, K., Aoki, W., Ueda, M., Kozik, A., & Rapala-Kozik, M. (2017). Aspartic Proteases and Major Cell Wall Components in Candida albicans Trigger the Release of Neutrophil Extracellular Traps . In Frontiers in Cellular and Infection Microbiology (Vol. 7, p.414). 
    https://www.frontiersin.org/article/10.3389/fcimb.2017.00414
  34. Nenoff, P., Haustein, U. F., & Brandt, W. (1996). Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacology and Physiology, 9(6), 388-394.
  35. Hammer, K. A., Carson, C. F., & Riley, T. V. (2002). In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. Journal of Antimicrobial Chemotherapy, 50(2), 195-199.
  36. Tong, M. M., Altman, P. M., & Barnetson, R. S. (1992). Tea tree oil in the treatment of tinea pedis. Australasian Journal of Dermatology, 33(3), 145-149.
  37. Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract. 1994 Jun;38(6):601-5. PMID: 8195735.
  38. Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health. 1999 Apr;4(4):284-7. doi: 10.1046/j.1365-3156.1999.00396.x. PMID: 10357864.
  39. Cavanagh, H. T. T., & Wilkinson, J. T. (2002). Biological activities of lavender essential oil. Phytotherapy research, 16(4), 301-308.
  40. Inouye, S., Watanabe, M., Nishiyama, Y., Takeo, K., Akao, M., & Yamaguchi, H. (1998). Antisporulating and respiration‐inhibitory effects of essential oils on filamentous fungi: Hemmeffekte ätherischer Öle auf Sporulation und Atmung von Fadenpilzen. Mycoses, 41(9‐10), 403-410.
  41. Bahmani, M., & Schmidt, O. (2018). Plant essential oils for environment-friendly protection of wood objects against fungi. Maderas. Ciencia y tecnología, 20(3), 325-332.
  42. Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Rouabhia M, Mahdouani K, Bakhrouf A. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother Res. 2007 Jun;21(6):501-6. doi: 10.1002/ptr.2124. PMID: 17380552.
  43. Rajkowska K, Nowicka-Krawczyk P, Kunicka-Styczyńska A. Effect of Clove and Thyme Essential Oils on Candida Biofilm Formation and the Oil Distribution in Yeast Cells. Molecules. 2019 May 21;24(10):1954. doi: 10.3390/molecules24101954. PMID: 31117281; PMCID: PMC6572016.
  44. Akihisa, T., Nakamura, Y., Tagata, M., Tokuda, H., Yasukawa, K., Uchiyama, E., Suzuki, T. and Kimura, Y. (2007), Anti‐Inflammatory and Anti‐Tumor‐Promoting Effects of Triterpene Acids and Sterols from the Fungus Ganoderma lucidum. Chemistry & Biodiversity, 4: 224-231. 
    https://doi.org/10.1002/cbdv.200790027
  45. Paterson RR. Ganoderma - a therapeutic fungal biofactory. Phytochemistry. 2006 Sep;67(18):1985-2001. doi: 10.1016/j.phytochem.2006.07.004. Epub 2006 Aug 14. PMID: 16905165.
  46. Clark, A.M., Jurgens, T.M. and Hufford, C.D. (1990), Antimicrobial activity of juglone. Phytother. Res., 4: 11-14. 
    https://doi.org/10.1002/ptr.2650040104